Global Gastrointestinal Disorder Therapeutics Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Gastrointestinal Disorder Therapeutics Market Size 2017-2028

2.1.2 Gastrointestinal Disorder Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Gastrointestinal Disorder Therapeutics Segment by Type

2.2.1 Irritable Bowel Syndrome (IBS)

2.2.2 Chronic Constipation (CC)

2.2.3 Ulcerative Colitis (UC)

2.3 Gastrointestinal Disorder Therapeutics Market Size by Type

2.3.1 Gastrointestinal Disorder Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Gastrointestinal Disorder Therapeutics Market Size Market Share by Type (2017-2022)

2.4 Gastrointestinal Disorder Therapeutics Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Others

2.5 Gastrointestinal Disorder Therapeutics Market Size by Application

2.5.1 Gastrointestinal Disorder Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Gastrointestinal Disorder Therapeutics Market Size Market Share by Application (2017-2022)

3 Gastrointestinal Disorder Therapeutics Market Size by Player

3.1 Gastrointestinal Disorder Therapeutics Market Size Market Share by Players

3.1.1 Global Gastrointestinal Disorder Therapeutics Revenue by Players (2020-2022)

3.1.2 Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Players (2020-2022)

3.2 Global Gastrointestinal Disorder Therapeutics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Gastrointestinal Disorder Therapeutics by Regions

4.1 Gastrointestinal Disorder Therapeutics Market Size by Regions (2017-2022)

4.2 Americas Gastrointestinal Disorder Therapeutics Market Size Growth (2017-2022)

4.3 APAC Gastrointestinal Disorder Therapeutics Market Size Growth (2017-2022)

4.4 Europe Gastrointestinal Disorder Therapeutics Market Size Growth (2017-2022)

4.5 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size Growth (2017-2022)

5 Americas

5.1 Americas Gastrointestinal Disorder Therapeutics Market Size by Country (2017-2022)

5.2 Americas Gastrointestinal Disorder Therapeutics Market Size by Type (2017-2022)

5.3 Americas Gastrointestinal Disorder Therapeutics Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Gastrointestinal Disorder Therapeutics Market Size by Region (2017-2022)

6.2 APAC Gastrointestinal Disorder Therapeutics Market Size by Type (2017-2022)

6.3 APAC Gastrointestinal Disorder Therapeutics Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Gastrointestinal Disorder Therapeutics by Country (2017-2022)

7.2 Europe Gastrointestinal Disorder Therapeutics Market Size by Type (2017-2022)

7.3 Europe Gastrointestinal Disorder Therapeutics Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Gastrointestinal Disorder Therapeutics by Region (2017-2022)

8.2 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Type (2017-2022)

8.3 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Gastrointestinal Disorder Therapeutics Market Forecast

10.1 Global Gastrointestinal Disorder Therapeutics Forecast by Regions (2023-2028)

10.1.1 Global Gastrointestinal Disorder Therapeutics Forecast by Regions (2023-2028)

10.1.2 Americas Gastrointestinal Disorder Therapeutics Forecast

10.1.3 APAC Gastrointestinal Disorder Therapeutics Forecast

10.1.4 Europe Gastrointestinal Disorder Therapeutics Forecast

10.1.5 Middle East & Africa Gastrointestinal Disorder Therapeutics Forecast

10.2 Americas Gastrointestinal Disorder Therapeutics Forecast by Country (2023-2028)

10.2.1 United States Gastrointestinal Disorder Therapeutics Market Forecast

10.2.2 Canada Gastrointestinal Disorder Therapeutics Market Forecast

10.2.3 Mexico Gastrointestinal Disorder Therapeutics Market Forecast

10.2.4 Brazil Gastrointestinal Disorder Therapeutics Market Forecast

10.3 APAC Gastrointestinal Disorder Therapeutics Forecast by Region (2023-2028)

10.3.1 China Gastrointestinal Disorder Therapeutics Market Forecast

10.3.2 Japan Gastrointestinal Disorder Therapeutics Market Forecast

10.3.3 Korea Gastrointestinal Disorder Therapeutics Market Forecast

10.3.4 Southeast Asia Gastrointestinal Disorder Therapeutics Market Forecast

10.3.5 India Gastrointestinal Disorder Therapeutics Market Forecast

10.3.6 Australia Gastrointestinal Disorder Therapeutics Market Forecast

10.4 Europe Gastrointestinal Disorder Therapeutics Forecast by Country (2023-2028)

10.4.1 Germany Gastrointestinal Disorder Therapeutics Market Forecast

10.4.2 France Gastrointestinal Disorder Therapeutics Market Forecast

10.4.3 UK Gastrointestinal Disorder Therapeutics Market Forecast

10.4.4 Italy Gastrointestinal Disorder Therapeutics Market Forecast

10.4.5 Russia Gastrointestinal Disorder Therapeutics Market Forecast

10.5 Middle East & Africa Gastrointestinal Disorder Therapeutics Forecast by Region (2023-2028)

10.5.1 Egypt Gastrointestinal Disorder Therapeutics Market Forecast

10.5.2 South Africa Gastrointestinal Disorder Therapeutics Market Forecast

10.5.3 Israel Gastrointestinal Disorder Therapeutics Market Forecast

10.5.4 Turkey Gastrointestinal Disorder Therapeutics Market Forecast

10.5.5 GCC Countries Gastrointestinal Disorder Therapeutics Market Forecast

10.6 Global Gastrointestinal Disorder Therapeutics Forecast by Type (2023-2028)

10.7 Global Gastrointestinal Disorder Therapeutics Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 AstraZeneca

11.1.1 AstraZeneca Company Information

11.1.2 AstraZeneca Gastrointestinal Disorder Therapeutics Product Offered

11.1.3 AstraZeneca Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 AstraZeneca Main Business Overview

11.1.5 AstraZeneca Latest Developments

11.2 Takeda Pharmaceutical

11.2.1 Takeda Pharmaceutical Company Information

11.2.2 Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Product Offered

11.2.3 Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Takeda Pharmaceutical Main Business Overview

11.2.5 Takeda Pharmaceutical Latest Developments

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Company Information

11.3.2 Johnson & Johnson Gastrointestinal Disorder Therapeutics Product Offered

11.3.3 Johnson & Johnson Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Johnson & Johnson Main Business Overview

11.3.5 Johnson & Johnson Latest Developments

11.4 Eisai

11.4.1 Eisai Company Information

11.4.2 Eisai Gastrointestinal Disorder Therapeutics Product Offered

11.4.3 Eisai Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Eisai Main Business Overview

11.4.5 Eisai Latest Developments

11.5 Abbott Laboratories

11.5.1 Abbott Laboratories Company Information

11.5.2 Abbott Laboratories Gastrointestinal Disorder Therapeutics Product Offered

11.5.3 Abbott Laboratories Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Abbott Laboratories Main Business Overview

11.5.5 Abbott Laboratories Latest Developments

11.6 Salix Pharmaceuticals

11.6.1 Salix Pharmaceuticals Company Information

11.6.2 Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Product Offered

11.6.3 Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Salix Pharmaceuticals Main Business Overview

11.6.5 Salix Pharmaceuticals Latest Developments

11.7 Bausch Health

11.7.1 Bausch Health Company Information

11.7.2 Bausch Health Gastrointestinal Disorder Therapeutics Product Offered

11.7.3 Bausch Health Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Bausch Health Main Business Overview

11.7.5 Bausch Health Latest Developments

11.8 Allergan

11.8.1 Allergan Company Information

11.8.2 Allergan Gastrointestinal Disorder Therapeutics Product Offered

11.8.3 Allergan Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Allergan Main Business Overview

11.8.5 Allergan Latest Developments

11.9 Bayer

11.9.1 Bayer Company Information

11.9.2 Bayer Gastrointestinal Disorder Therapeutics Product Offered

11.9.3 Bayer Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Bayer Main Business Overview

11.9.5 Bayer Latest Developments

11.10 UCB

11.10.1 UCB Company Information

11.10.2 UCB Gastrointestinal Disorder Therapeutics Product Offered

11.10.3 UCB Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 UCB Main Business Overview

11.10.5 UCB Latest Developments

11.11 AbbVie

11.11.1 AbbVie Company Information

11.11.2 AbbVie Gastrointestinal Disorder Therapeutics Product Offered

11.11.3 AbbVie Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 AbbVie Main Business Overview

11.11.5 AbbVie Latest Developments

11.12 GlaxoSmithKline

11.12.1 GlaxoSmithKline Company Information

11.12.2 GlaxoSmithKline Gastrointestinal Disorder Therapeutics Product Offered

11.12.3 GlaxoSmithKline Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 GlaxoSmithKline Main Business Overview

11.12.5 GlaxoSmithKline Latest Developments

11.13 Astellas Pharma

11.13.1 Astellas Pharma Company Information

11.13.2 Astellas Pharma Gastrointestinal Disorder Therapeutics Product Offered

11.13.3 Astellas Pharma Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Astellas Pharma Main Business Overview

11.13.5 Astellas Pharma Latest Developments

12 Research Findings and Conclusion

Table 1. Gastrointestinal Disorder Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Irritable Bowel Syndrome (IBS)

Table 3. Major Players of Chronic Constipation (CC)

Table 4. Major Players of Ulcerative Colitis (UC)

Table 5. Gastrointestinal Disorder Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global Gastrointestinal Disorder Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global Gastrointestinal Disorder Therapeutics Market Size Market Share by Type (2017-2022)

Table 8. Gastrointestinal Disorder Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Gastrointestinal Disorder Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global Gastrointestinal Disorder Therapeutics Market Size Market Share by Application (2017-2022)

Table 11. Global Gastrointestinal Disorder Therapeutics Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Player (2020-2022)

Table 13. Gastrointestinal Disorder Therapeutics Key Players Head office and Products Offered

Table 14. Gastrointestinal Disorder Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global Gastrointestinal Disorder Therapeutics Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global Gastrointestinal Disorder Therapeutics Market Size Market Share by Regions (2017-2022)

Table 19. Americas Gastrointestinal Disorder Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas Gastrointestinal Disorder Therapeutics Market Size Market Share by Country (2017-2022)

Table 21. Americas Gastrointestinal Disorder Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas Gastrointestinal Disorder Therapeutics Market Size Market Share by Type (2017-2022)

Table 23. Americas Gastrointestinal Disorder Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas Gastrointestinal Disorder Therapeutics Market Size Market Share by Application (2017-2022)

Table 25. APAC Gastrointestinal Disorder Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC Gastrointestinal Disorder Therapeutics Market Size Market Share by Region (2017-2022)

Table 27. APAC Gastrointestinal Disorder Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC Gastrointestinal Disorder Therapeutics Market Size Market Share by Type (2017-2022)

Table 29. APAC Gastrointestinal Disorder Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC Gastrointestinal Disorder Therapeutics Market Size Market Share by Application (2017-2022)

Table 31. Europe Gastrointestinal Disorder Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe Gastrointestinal Disorder Therapeutics Market Size Market Share by Country (2017-2022)

Table 33. Europe Gastrointestinal Disorder Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe Gastrointestinal Disorder Therapeutics Market Size Market Share by Type (2017-2022)

Table 35. Europe Gastrointestinal Disorder Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe Gastrointestinal Disorder Therapeutics Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of Gastrointestinal Disorder Therapeutics

Table 44. Key Market Challenges & Risks of Gastrointestinal Disorder Therapeutics

Table 45. Key Industry Trends of Gastrointestinal Disorder Therapeutics

Table 46. Global Gastrointestinal Disorder Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global Gastrointestinal Disorder Therapeutics Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global Gastrointestinal Disorder Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global Gastrointestinal Disorder Therapeutics Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global Gastrointestinal Disorder Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global Gastrointestinal Disorder Therapeutics Market Size Market Share Forecast by Application (2023-2028)

Table 52. AstraZeneca Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors

Table 53. AstraZeneca Gastrointestinal Disorder Therapeutics Product Offered

Table 54. AstraZeneca Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. AstraZeneca Main Business

Table 56. AstraZeneca Latest Developments

Table 57. Takeda Pharmaceutical Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors

Table 58. Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Product Offered

Table 59. Takeda Pharmaceutical Main Business

Table 60. Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. Takeda Pharmaceutical Latest Developments

Table 62. Johnson & Johnson Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors

Table 63. Johnson & Johnson Gastrointestinal Disorder Therapeutics Product Offered

Table 64. Johnson & Johnson Main Business

Table 65. Johnson & Johnson Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Johnson & Johnson Latest Developments

Table 67. Eisai Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors

Table 68. Eisai Gastrointestinal Disorder Therapeutics Product Offered

Table 69. Eisai Main Business

Table 70. Eisai Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Eisai Latest Developments

Table 72. Abbott Laboratories Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors

Table 73. Abbott Laboratories Gastrointestinal Disorder Therapeutics Product Offered

Table 74. Abbott Laboratories Main Business

Table 75. Abbott Laboratories Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Abbott Laboratories Latest Developments

Table 77. Salix Pharmaceuticals Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors

Table 78. Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Product Offered

Table 79. Salix Pharmaceuticals Main Business

Table 80. Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Salix Pharmaceuticals Latest Developments

Table 82. Bausch Health Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors

Table 83. Bausch Health Gastrointestinal Disorder Therapeutics Product Offered

Table 84. Bausch Health Main Business

Table 85. Bausch Health Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. Bausch Health Latest Developments

Table 87. Allergan Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors

Table 88. Allergan Gastrointestinal Disorder Therapeutics Product Offered

Table 89. Allergan Main Business

Table 90. Allergan Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Allergan Latest Developments

Table 92. Bayer Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors

Table 93. Bayer Gastrointestinal Disorder Therapeutics Product Offered

Table 94. Bayer Main Business

Table 95. Bayer Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. Bayer Latest Developments

Table 97. UCB Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors

Table 98. UCB Gastrointestinal Disorder Therapeutics Product Offered

Table 99. UCB Main Business

Table 100. UCB Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. UCB Latest Developments

Table 102. AbbVie Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors

Table 103. AbbVie Gastrointestinal Disorder Therapeutics Product Offered

Table 104. AbbVie Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 105. AbbVie Main Business

Table 106. AbbVie Latest Developments

Table 107. GlaxoSmithKline Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors

Table 108. GlaxoSmithKline Gastrointestinal Disorder Therapeutics Product Offered

Table 109. GlaxoSmithKline Main Business

Table 110. GlaxoSmithKline Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 111. GlaxoSmithKline Latest Developments

Table 112. Astellas Pharma Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors

Table 113. Astellas Pharma Gastrointestinal Disorder Therapeutics Product Offered

Table 114. Astellas Pharma Main Business

Table 115. Astellas Pharma Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 116. Astellas Pharma Latest Developments

List of Figures

Figure 1. Gastrointestinal Disorder Therapeutics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Gastrointestinal Disorder Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Gastrointestinal Disorder Therapeutics Market Size Market Share by Type in 2021

Figure 7. Gastrointestinal Disorder Therapeutics in Hospitals

Figure 8. Global Gastrointestinal Disorder Therapeutics Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. Gastrointestinal Disorder Therapeutics in Clinics

Figure 10. Global Gastrointestinal Disorder Therapeutics Market: Clinics (2017-2022) & ($ Millions)

Figure 11. Gastrointestinal Disorder Therapeutics in Others

Figure 12. Global Gastrointestinal Disorder Therapeutics Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Gastrointestinal Disorder Therapeutics Market Size Market Share by Application in 2021

Figure 14. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Player in 2021

Figure 15. Global Gastrointestinal Disorder Therapeutics Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Gastrointestinal Disorder Therapeutics Market Size 2017-2022 ($ Millions)

Figure 17. APAC Gastrointestinal Disorder Therapeutics Market Size 2017-2022 ($ Millions)

Figure 18. Europe Gastrointestinal Disorder Therapeutics Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size 2017-2022 ($ Millions)

Figure 20. Americas Gastrointestinal Disorder Therapeutics Value Market Share by Country in 2021

Figure 21. Americas Gastrointestinal Disorder Therapeutics Consumption Market Share by Type in 2021

Figure 22. Americas Gastrointestinal Disorder Therapeutics Market Size Market Share by Application in 2021

Figure 23. United States Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Gastrointestinal Disorder Therapeutics Market Size Market Share by Region in 2021

Figure 28. APAC Gastrointestinal Disorder Therapeutics Market Size Market Share by Application in 2021

Figure 29. China Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Gastrointestinal Disorder Therapeutics Market Size Market Share by Country in 2021

Figure 36. Europe Gastrointestinal Disorder Therapeutics Market Size Market Share by Type in 2021

Figure 37. Europe Gastrointestinal Disorder Therapeutics Market Size Market Share by Application in 2021

Figure 38. Germany Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size Market Share by Application in 2021

Figure 46. Egypt Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 52. APAC Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 53. Europe Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 55. United States Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 56. Canada Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 59. China Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 60. Japan Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 61. Korea Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 63. India Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 64. Australia Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 65. Germany Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 66. France Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 67. UK Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 68. Italy Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 69. Russia Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 70. Spain Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 73. Israel Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)